Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - United States
Summary - Independent Verification And Validation Of Engineered Cell Lines
Deadline - May 16, 2025
GT reference number - 108101071
Product classification - Business services: law, marketing, consulting, recruitment, printing and security
Address - United States
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 108101071
Document Type - Tender Notices
Description - Description: BACKGROUND The Advanced Research Projects Agency for Health (ARPA-H) Resilient Systems Office seeks to support the procurement of independent verification and validation (IV&V) of the engineered cell lines utilized in the Resilient Exten ded Automatic Cell Therapies (REACT) program. The REACT program is developing wireless implantable medical devices for the surveillance and treatment of chronic diseases. These devices will interface with patients through a software platform, allowing for confirmation of therapy delivery or current disease status. The “Living Pharmacy” device will deliver tunable therapeutic molecules on demand, while the “Living Sentinel” device will tra
Gt Ref Id - 108101071
Deadline - May 16, 2025
Similar Tenders :
Summary:
|
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database